山东医药2023，Vol.63Issue(25)：1-4,27,5.DOI:10.3969/j.issn.1002-266X.2023.25.001
慢性阻塞性肺疾病急性加重期患者血清miR-181a和Smad7 mRNA表达变化及其临床意义
Expression changes of serum miR-181a and Smad7 expression in patients with acute exacerbation of chronic obstructive pulmonary disease and their clinical significance
摘要
关键词
慢性阻塞性肺疾病急性加重期/微小RNA-181a/Smad同源物7/病情严重程度/气道重塑Key words
acute exacerbation of chronic obstructive pulmonary disease/microRNA-181a/Smad homolog 7/dis-ease severity/airway remodeling分类
医药卫生引用本文复制引用
梁颖隽,张小瑜,李小波..慢性阻塞性肺疾病急性加重期患者血清miR-181a和Smad7 mRNA表达变化及其临床意义[J].山东医药,2023,63(25):1-4,27,5.基金项目
四川省卫生健康科研课题立项项目(20PJ179). （20PJ179）
